2023 Q1 Form 10-K Financial Statement

#000160148523000011 Filed on March 17, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $2.301M
YoY Change -100.0% -100.0% -91.87%
Cost Of Revenue $0.00
YoY Change -100.0%
Gross Profit $2.301M
YoY Change -91.75%
Gross Profit Margin 100.0%
Selling, General & Admin $4.281M $3.745M $14.64M
YoY Change -4.14% -10.96% -20.83%
% of Gross Profit 636.11%
Research & Development $326.0K $160.0K $18.10M
YoY Change -97.21% -97.6% -62.83%
% of Gross Profit 786.61%
Depreciation & Amortization $22.00K $31.00K $200.0K
YoY Change -31.25% -3.13% 100.0%
% of Gross Profit 8.69%
Operating Expenses $326.0K $3.905M $18.10M
YoY Change -97.21% -64.09% -62.83%
Operating Profit -$4.607M -$39.62M
YoY Change -68.19% 0.8%
Interest Expense $382.0K $606.0K $719.0K
YoY Change 85.44% -3887.5% -132.82%
% of Operating Profit
Other Income/Expense, Net $70.00K $5.000K $814.0K
YoY Change -71.43% -98.16% -105.33%
Pretax Income -$4.537M -$6.440M -$38.80M
YoY Change -68.14% -143.25% -28.91%
Income Tax $0.00 $11.00K
% Of Pretax Income
Net Earnings -$4.537M -$6.440M -$38.81M
YoY Change -68.14% -143.25% -28.89%
Net Earnings / Revenue -1686.53%
Basic Earnings Per Share -$0.15 -$1.29
Diluted Earnings Per Share -$0.15 -$0.21 -$1.29
COMMON SHARES
Basic Shares Outstanding 30.11M shares 30.11M shares 30.04M shares
Diluted Shares Outstanding 30.11M shares 30.04M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $29.22M $50.49M $50.49M
YoY Change -59.98% -43.12% -43.12%
Cash & Equivalents $29.20M $50.50M $50.49M
Short-Term Investments
Other Short-Term Assets $405.0K $246.0K $943.0K
YoY Change -11.96% -50.6% -44.04%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $40.63M $51.43M $51.43M
YoY Change -46.71% -43.64% -43.64%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $273.0K $425.0K
YoY Change -100.0% -39.47% -90.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $150.0K $874.0K $874.0K
YoY Change -79.51% 20.89% 20.89%
Other Assets $864.0K $61.00K $61.00K
YoY Change 1007.69% -42.45% -42.45%
Total Long-Term Assets $1.140M $1.360M $1.360M
YoY Change -77.29% -74.17% -74.17%
TOTAL ASSETS
Total Short-Term Assets $40.63M $51.43M $51.43M
Total Long-Term Assets $1.140M $1.360M $1.360M
Total Assets $41.77M $52.79M $52.79M
YoY Change -48.6% -45.3% -45.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $692.0K $2.720M $2.720M
YoY Change -79.84% -42.25% -42.25%
Accrued Expenses $1.103M $2.569M $1.991M
YoY Change -78.96% -20.19% -51.59%
Deferred Revenue $0.00
YoY Change -100.0%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $67.00K $67.00K
YoY Change -100.0% 15.52% 15.52%
Total Short-Term Liabilities $2.031M $6.369M $6.369M
YoY Change -80.44% -43.62% -43.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $168.0K $168.0K
YoY Change -100.0% -28.51%
Other Long-Term Liabilities $70.00K $2.481M $2.481M
YoY Change -68.18% -28.6%
Total Long-Term Liabilities $70.00K $2.649M $2.649M
YoY Change -68.18% -28.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.031M $6.369M $6.369M
Total Long-Term Liabilities $70.00K $2.649M $2.649M
Total Liabilities $2.101M $9.018M $9.018M
YoY Change -85.05% -39.9% -39.9%
SHAREHOLDERS EQUITY
Retained Earnings -$258.5M -$253.9M
YoY Change 12.69% 18.02%
Common Stock $301.0K $301.0K
YoY Change 0.33% 0.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $39.67M $43.77M $43.77M
YoY Change
Total Liabilities & Shareholders Equity $41.77M $52.79M $52.79M
YoY Change -48.6% -45.3% -45.3%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$4.537M -$6.440M -$38.81M
YoY Change -68.14% -143.25% -28.89%
Depreciation, Depletion And Amortization $22.00K $31.00K $200.0K
YoY Change -31.25% -3.13% 100.0%
Cash From Operating Activities -$8.079M -$4.426M -$38.39M
YoY Change -48.39% -69.18% -27.07%
INVESTING ACTIVITIES
Capital Expenditures $17.00K $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities -$10.00M
YoY Change
Cash From Investing Activities -$10.00M $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$3.268M -15.00K -$60.00K
YoY Change 23242.86% -103.71% -100.06%
NET CHANGE
Cash From Operating Activities -$8.079M -4.426M -$38.39M
Cash From Investing Activities -$10.00M 0.000 $0.00
Cash From Financing Activities -$3.268M -15.00K -$60.00K
Net Change In Cash -$21.27M -4.441M -$38.27M
YoY Change 35.0% -68.26% -170.67%
FREE CASH FLOW
Cash From Operating Activities -$8.079M -$4.426M -$38.39M
Capital Expenditures $17.00K $0.00 $0.00
Free Cash Flow -$8.096M -$4.426M -$38.39M
YoY Change -48.28% -69.11% -27.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001601485
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
34300000 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30114190 shares
CY2022 dei Auditor Name
AuditorName
Moss Adams LLP
CY2022 dei Auditor Location
AuditorLocation
Seattle, Washington
CY2022 dei Auditor Firm
AuditorFirmId
659
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50487000 usd
CY2022Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
0 usd
CY2021Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
806000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
943000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
51430000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
273000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
152000 usd
CY2022Q4 us-gaap Investments
Investments
874000 usd
CY2021Q4 us-gaap Investments
Investments
723000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
61000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
106000 usd
CY2022Q4 us-gaap Assets
Assets
52790000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2720000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2569000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
994000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
894000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
67000 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
58000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2301000 usd
CY2022Q4 angn Warrant Liability Current
WarrantLiabilityCurrent
19000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6369000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2481000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
168000 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
235000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
9018000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30113946 shares
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
297327000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
296445000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
86000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-103000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-253942000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-215135000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
43772000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
81507000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52790000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
96513000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2301000 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
27506000 usd
CY2022 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
0 usd
CY2021 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
806000 usd
CY2022 us-gaap Revenues
Revenues
2301000 usd
CY2021 us-gaap Revenues
Revenues
28312000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
433000 usd
CY2022 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
9185000 usd
CY2021 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-95000 usd
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2919000 usd
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
0 usd
CY2021 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-7469000 usd
CY2022 angn Financial Instruments Subject To Mandatory Redemption By Settlement Terms Change In Fair Value Gain Loss
FinancialInstrumentsSubjectToMandatoryRedemptionBySettlementTermsChangeInFairValueGainLoss
0 usd
CY2021 angn Financial Instruments Subject To Mandatory Redemption By Settlement Terms Change In Fair Value Gain Loss
FinancialInstrumentsSubjectToMandatoryRedemptionBySettlementTermsChangeInFairValueGainLoss
-3592000 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-237000 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-245000 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
905000 usd
CY2022 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
151000 usd
CY2021 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-99000 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
805000 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1847000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
814000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15266000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-38807000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-54573000 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
189000 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
230000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38618000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-54343000 usd
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.29
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.29
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.93
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.93
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30040703 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30040703 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28244825 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28244825 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
81507000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
43772000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-90449000 usd
CY2021 angn Stock Issued During Period Value Conversion Of Convertible Preferred Stock
StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStock
35754000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
10000 usd
CY2021 angn Stock Issued During Period Value Broker Warrants Exercised
StockIssuedDuringPeriodValueBrokerWarrantsExercised
0 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
980000 usd
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
18000 usd
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2458000 usd
CY2021 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12041000 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
230000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-54573000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-38807000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-54573000 usd
CY2022 us-gaap Depreciation
Depreciation
178000 usd
CY2021 us-gaap Depreciation
Depreciation
91000 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
813000 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
710000 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1884000 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
905000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
885000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
12041000 usd
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
0 usd
CY2021 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-7469000 usd
CY2022 angn Financial Instruments Subject To Mandatory Redemption By Settlement Terms Change In Fair Value Gain Loss
FinancialInstrumentsSubjectToMandatoryRedemptionBySettlementTermsChangeInFairValueGainLoss
0 usd
CY2021 angn Financial Instruments Subject To Mandatory Redemption By Settlement Terms Change In Fair Value Gain Loss
FinancialInstrumentsSubjectToMandatoryRedemptionBySettlementTermsChangeInFairValueGainLoss
-3592000 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-95000 usd
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2919000 usd
CY2022 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
3021000 usd
CY2021 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
151000 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-96000 usd
CY2022 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 usd
CY2021 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3000 usd
CY2022 angn Increase Decrease In Grant Receivables
IncreaseDecreaseInGrantReceivables
-806000 usd
CY2021 angn Increase Decrease In Grant Receivables
IncreaseDecreaseInGrantReceivables
806000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-806000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4016000 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-45000 usd
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
106000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2050000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-866000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-646000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
11000 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-894000 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-713000 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2301000 usd
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-27506000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38390000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-52643000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
382000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-382000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
107487000 usd
CY2022 angn Proceeds From Financing Obligation
ProceedsFromFinancingObligation
0 usd
CY2021 angn Proceeds From Financing Obligation
ProceedsFromFinancingObligation
302000 usd
CY2022 angn Proceeds From Rsu Settlement Net Of Payment Of Taxes
ProceedsFromRSUSettlementNetOfPaymentOfTaxes
-2000 usd
CY2021 angn Proceeds From Rsu Settlement Net Of Payment Of Taxes
ProceedsFromRSUSettlementNetOfPaymentOfTaxes
18000 usd
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
58000 usd
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
9000 usd
CY2022 angn Payments For Forward Stock Split Fractional Shares
PaymentsForForwardStockSplitFractionalShares
0 usd
CY2021 angn Payments For Forward Stock Split Fractional Shares
PaymentsForForwardStockSplitFractionalShares
10000 usd
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2458000 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
861000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
980000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-60000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
107171000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
181000 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-38269000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
54149000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88756000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34607000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50487000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88756000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
7000 usd
CY2022 angn Stock Retired
StockRetired
0 usd
CY2021 angn Stock Retired
StockRetired
4210000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
624000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4000 usd
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.55583
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
16.00
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
16.00
CY2021Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50500000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-253900000 usd
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 operatingsegment
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
305000 usd
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
781000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
246000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to the useful lives of long-lived assets, fair value of the long-lived assets, the measurement of stock-based compensation, change in fair value of warrant liabilities prior to IPO, accruals for research and development activities, income taxes and revenue recognition. The Company bases its estimates on historical experience and on other relevant assumptions that are reasonable under the circumstances. Actual results could materially differ from those estimates.</span></div>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk and Off-Balance Sheet Risk</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are financial instruments that are potentially subject to concentrations of credit risk. The Company maintains its cash equivalents in securities and money market funds with original maturities less than three months. Substantially all of the Company's cash and cash equivalents are held at Silicon Valley Bank (SVB), and the amounts frequently exceed federally insured limits. On March 10, 2023, the Federal Deposit Insurance Corporation (FDIC) announced that SVB had been closed by the California Department of Financial Protection and Innovation. The United States Department of the Treasury announced in a joint statement with the Federal Reserve and FDIC that depositors of SVB will have access to all of their money starting March 13, 2023, including funds exceeding federally insured limits. The Company is exposed to credit risk in the event of default by the financial institutions holding its cash and cash equivalents. If the Company is unable to access our cash and cash equivalents as needed, its financial position and ability to operate its business will be adversely affected.</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company established guidelines regarding approved investments and maturities of investments, which are designed to maintain safety and liquidity.</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has no financial instruments with off-balance sheet risk of loss.</span></div>
CY2022 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
3000000 usd
CY2021 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
498000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
943000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1685000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
968000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
968000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
695000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
517000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
273000 usd
CY2022 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
0 usd
CY2021 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
800000 usd
CY2022Q4 angn Number Of Performance Obligations
NumberOfPerformanceObligations
1 performanceobligation
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
291000 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
275000 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
101000 usd
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
131000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
451000 usd
CY2022 us-gaap Depreciation
Depreciation
200000 usd
CY2021 us-gaap Depreciation
Depreciation
100000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
112000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1274000 usd
CY2022Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1572000 usd
CY2021Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
0 usd
CY2022Q4 angn Accrued Direct Research Costs Current
AccruedDirectResearchCostsCurrent
774000 usd
CY2021Q4 angn Accrued Direct Research Costs Current
AccruedDirectResearchCostsCurrent
1196000 usd
CY2022Q4 angn Accrued Operating Liabilities Current
AccruedOperatingLiabilitiesCurrent
111000 usd
CY2021Q4 angn Accrued Operating Liabilities Current
AccruedOperatingLiabilitiesCurrent
749000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2569000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3219000 usd
CY2022 angn Number Of Votes Per Share Of Common Stock
NumberOfVotesPerShareOfCommonStock
1 vote
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4230162 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.92
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2257100 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.93
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2761015 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.73
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3726247 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.30
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2493026 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.78
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y2M12D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.18
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.25
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1400000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
885000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12041000 usd
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1148123 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1148123 shares
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
11000 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
11000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
1317000 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
1142000 usd
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
350000 usd
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
473000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
18000 usd
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
44000 usd
CY2022 us-gaap Lease Cost
LeaseCost
1685000 usd
CY2021 us-gaap Lease Cost
LeaseCost
1659000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
1289000 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1179000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
624000 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y1M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.095
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.101
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1305000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1209000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1104000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
516000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4134000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
659000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3475000 usd
CY2021Q4 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P42M
CY2021 angn Proceeds From Financing Obligation
ProceedsFromFinancingObligation
300000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-6710000 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-5460000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-699000 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-4779000 usd
CY2022 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
7409000 usd
CY2021 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
10239000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
36000 usd
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
58000 usd
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.011
CY2022Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
94000 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
94000 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
31000 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
219000 usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
900000 usd
CY2022Q4 angn Cares Act Employee Retention Credit
CARESActEmployeeRetentionCredit
0 usd
CY2021Q4 angn Cares Act Employee Retention Credit
CARESActEmployeeRetentionCredit
1500000 usd
CY2022 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
3000000 usd
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-38302000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-53547000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-496000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1026000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38798000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54573000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.023
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.023
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.003
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.001
CY2022 angn Effective Income Tax Rate Reconciliation Interest Percent
EffectiveIncomeTaxRateReconciliationInterestPercent
0
CY2021 angn Effective Income Tax Rate Reconciliation Interest Percent
EffectiveIncomeTaxRateReconciliationInterestPercent
-0.043
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.014
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.028
CY2022 angn Effective Income Tax Rate Reconciliation Permanent Items Percent
EffectiveIncomeTaxRateReconciliationPermanentItemsPercent
-0.003
CY2021 angn Effective Income Tax Rate Reconciliation Permanent Items Percent
EffectiveIncomeTaxRateReconciliationPermanentItemsPercent
-0.073
CY2022 us-gaap Effective Income Tax Rate Reconciliation Gilti Percent
EffectiveIncomeTaxRateReconciliationGiltiPercent
-0.003
CY2021 us-gaap Effective Income Tax Rate Reconciliation Gilti Percent
EffectiveIncomeTaxRateReconciliationGiltiPercent
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
-0.003
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.192
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.101
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
32659000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
29211000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
7444000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
6752000 usd
CY2022Q4 angn Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
879000 usd
CY2021Q4 angn Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
1224000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1005000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3070000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
149000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
536000 usd
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
5020000 usd
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
47156000 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
40793000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
37000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
38000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1046000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47118000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
39710000 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
133500000 usd
CY2022Q4 angn Operating Loss Carryforward Subject To Expiration
OperatingLossCarryforwardSubjectToExpiration
9600000 usd
CY2022Q4 angn Operating Loss Carryforward Not Subject To Expiration
OperatingLossCarryforwardNotSubjectToExpiration
123800000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4300000 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3675000 usd
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2579000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
386000 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1073000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
246000 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
23000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4307000 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3675000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0 usd
CY2022Q4 angn Unrecognized Tax Benefits That Would Not Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate
4307000 usd
CY2021Q4 angn Unrecognized Tax Benefits That Would Not Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldNotImpactEffectiveTaxRate
3675000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4307000 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3675000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-38807000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-54573000 usd
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30040703 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30040703 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28244825 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28244825 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.29
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.29
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.93
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.93
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4890416 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5581300 shares

Files In Submission

Name View Source Status
angn-20221231_pre.xml Edgar Link unprocessable
0001601485-23-000011-index-headers.html Edgar Link pending
0001601485-23-000011-index.html Edgar Link pending
0001601485-23-000011.txt Edgar Link pending
0001601485-23-000011-xbrl.zip Edgar Link pending
a2022-10x27ohragreementf.htm Edgar Link pending
a2022-10x27ohragreementf001.jpg Edgar Link pending
a2022-10x27ohragreementf002.jpg Edgar Link pending
a2022-10x27ohragreementf003.jpg Edgar Link pending
a2022-10x27ohragreementf004.jpg Edgar Link pending
angn-20221231_cal.xml Edgar Link unprocessable
a2022-10x27ohragreementf005.jpg Edgar Link pending
angionohrlicenseagreeemn.htm Edgar Link pending
angionohrlicenseagreeemn001.jpg Edgar Link pending
angionohrlicenseagreeemn002.jpg Edgar Link pending
angionohrlicenseagreeemn003.jpg Edgar Link pending
angionohrlicenseagreeemn004.jpg Edgar Link pending
angionohrlicenseagreeemn005.jpg Edgar Link pending
angionohrlicenseagreeemn006.jpg Edgar Link pending
angionohrlicenseagreeemn007.jpg Edgar Link pending
angionohrlicenseagreeemn008.jpg Edgar Link pending
angionohrlicenseagreeemn009.jpg Edgar Link pending
angionohrlicenseagreeemn010.jpg Edgar Link pending
angionohrlicenseagreeemn011.jpg Edgar Link pending
angionohrlicenseagreeemn012.jpg Edgar Link pending
angionohrlicenseagreeemn013.jpg Edgar Link pending
angionohrlicenseagreeemn014.jpg Edgar Link pending
angionohrlicenseagreeemn015.jpg Edgar Link pending
angionohrlicenseagreeemn016.jpg Edgar Link pending
angionohrlicenseagreeemn017.jpg Edgar Link pending
angionohrlicenseagreeemn018.jpg Edgar Link pending
angn-20221231.htm Edgar Link pending
angn-20221231.xsd Edgar Link pending
ex231_angnx123122-10k.htm Edgar Link pending
ex311_angnx123122-10k.htm Edgar Link pending
ex312_angnx123122x10k.htm Edgar Link pending
ex321angn-12312022x10k.htm Edgar Link pending
ex322_angnx123122-10k.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
membershipinterestredemp.htm Edgar Link pending
membershipinterestredemp001.jpg Edgar Link pending
membershipinterestredemp002.jpg Edgar Link pending
membershipinterestredemp003.jpg Edgar Link pending
membershipinterestredemp004.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
angn-20221231_def.xml Edgar Link unprocessable
angn-20221231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
angn-20221231_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
surrenderagreement-angio.htm Edgar Link pending
surrenderagreement-angio001.jpg Edgar Link pending
surrenderagreement-angio002.jpg Edgar Link pending
surrenderagreement-angio003.jpg Edgar Link pending
surrenderagreement-angio004.jpg Edgar Link pending
surrenderagreement-angio005.jpg Edgar Link pending
surrenderagreement-angio006.jpg Edgar Link pending
surrenderagreement-angio007.jpg Edgar Link pending
surrenderagreement-angio008.jpg Edgar Link pending
surrenderagreement-angio009.jpg Edgar Link pending
surrenderagreement-angio010.jpg Edgar Link pending
surrenderagreement-angio011.jpg Edgar Link pending